113.90
Precedente Chiudi:
$115.61
Aprire:
$115.61
Volume 24 ore:
320.22K
Relative Volume:
0.59
Capitalizzazione di mercato:
$3.74B
Reddito:
$787.85M
Utile/perdita netta:
$-27.78M
Rapporto P/E:
-131.28
EPS:
-0.8676
Flusso di cassa netto:
$18.75M
1 W Prestazione:
-2.28%
1M Prestazione:
-5.67%
6M Prestazione:
-39.42%
1 anno Prestazione:
-19.92%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Nome
Irhythm Holdings Inc
Settore
Industria
Telefono
415-632-5700
Indirizzo
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
113.90 | 3.80B | 787.85M | -27.78M | 18.75M | -0.8676 |
|
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Iniziato | Evercore ISI | In-line |
| 2025-08-20 | Iniziato | BofA Securities | Buy |
| 2025-05-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Ripresa | Wells Fargo | Equal Weight |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-06-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-07 | Iniziato | Wells Fargo | Overweight |
| 2022-11-07 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-06 | Iniziato | Wolfe Research | Underperform |
| 2022-02-24 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-18 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-06-02 | Downgrade | Citigroup | Buy → Neutral |
| 2021-04-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Downgrade | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Reiterato | Needham | Hold |
| 2020-11-17 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Iniziato | Needham | Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-08-07 | Aggiornamento | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-10 | Iniziato | William Blair | Outperform |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-10-22 | Iniziato | Oppenheimer | Perform |
| 2019-02-20 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Reiterato | Canaccord Genuity | Buy |
| 2018-09-06 | Iniziato | Chardan Capital Markets | Buy |
| 2018-08-02 | Aggiornamento | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Downgrade | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Iniziato | Dougherty & Company | Neutral |
Mostra tutto
Irhythm Holdings Inc Borsa (IRTC) Ultime notizie
iRhythm Holdings (IRTC) director granted 1,573 RSUs in equity award - Stock Titan
Director Bruce Bodaken of iRhythm (NASDAQ: IRTC) receives 1,573 RSUs in equity grant - Stock Titan
Director at iRhythm (IRTC) receives 1,573 RSU equity award, now holds 11,141 shares - Stock Titan
Director at iRhythm (IRTC) granted 1,573 restricted stock units in equity award - Stock Titan
Director at iRhythm (NASDAQ: IRTC) receives 1,573 RSU award - Stock Titan
Director at iRhythm Holdings (IRTC) receives 1,573 restricted stock units - Stock Titan
Director at iRhythm (IRTC) awarded 1,573 restricted stock units in Form 4 - Stock Titan
iRhythm Holdings, Inc. Files Form 8-K Reporting Annual Shareholder Meeting Results and Company Details (May 27, 2026) - Minichart
iRhythm (IRTC) shareholders approve 2026 equity plan, directors and auditor - Stock Titan
IRTC: All five proposals, including director elections and governance changes, were approved - TradingView
iRhythm Holdings, Inc Annual Shareholders Meeting Transcript - GuruFocus
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring A 55% Upside Potential - DirectorsTalk Interviews
Here's why you should retain IRTC stock in your portfolio for now - MSN
What iRhythm Holdings (IRTC)'s Sustained Zio Growth and 2027 AI Launch Plan Means For Shareholders - Sahm
Digital health firm iRhythm lines up June investor conference talks - Stock Titan
iRhythm Holdings to Participate in Upcoming Investor Conferences - Yahoo Finance
IRTC Maintains Buy Rating -- Price Target Lowered to $180 by B o - GuruFocus
iRhythm Holdings, Inc. Stock 12‑Month Price Target Cut to $180.93, Implies 59% Upside - TradingView
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains - The Globe and Mail
Bessemer Group Inc. Decreases Position in iRhythm Technologies $IRTC - MarketBeat
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC: Q1 growth, LCD expansion, and AI-driven innovation position the business for continued momentum - TradingView
IRTC Technical Analysis | Trend, Signals & Chart Patterns | IRHYTHM HOLDINGS INC (NASDAQ:IRTC) - ChartMill
Irhythm Holdings Insider Sold Shares Worth $626,430, According to a Recent SEC Filing - Moomoo
Insider Buying: Abhijit Talwalkar Acquires Shares of iRhythm Hol - GuruFocus
Director at iRhythm (NASDAQ: IRTC) sells 5,312 shares in 10b5-1 trades - Stock Titan
IRTC (NASDAQ) director files Form 144 to sell 5,312 shares via exercise - Stock Titan
The sustainable advantages iRhythm Holdings (IRTC) is developing (Institutional Selling) 2026-05-11Value Investing - newser.com
IRhythm Holdings, Inc. (IRTC) Stock Analysis: High Growth Potential With A 52.61% Upside - DirectorsTalk Interviews
Net current asset value per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Will Strong Q1 Results And New Zio Data Change iRhythm Holdings' (IRTC) Narrative - Sahm
IRTC SEC FilingsiRhythm Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Sands Capital (IRTC) files Schedule 13G/A amendment on iRhythm ownership - Stock Titan
iRhythm stock rises on Medicare coverage update (IRTC:NASDAQ) - Seeking Alpha
Wall Street analysts predict a 57.21% upside in iRhythm Hldgs (IRTC): Here's what you should know - MSN
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock By Investing.com - Investing.com Nigeria
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock - Investing.com India
iRhythm (NASDAQ: IRTC) CTO sells 1,014 shares to cover RSU tax obligations - Stock Titan
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know - Yahoo Finance
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
Irhythm Holdings Inc Azioni (IRTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):